[HTML][HTML] Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
WM Zelek, RA Harrison - Immunobiology, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was identified in
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …
[HTML][HTML] Complement-mediated microvascular injury and thrombosis in the pathogenesis of severe COVID-19: A review
P Gianni, M Goldin, S Ngu, S Zafeiropoulos… - World Journal of …, 2022 - ncbi.nlm.nih.gov
Abstract Coronavirus disease 2019 (COVID-19) causes acute microvascular thrombosis in
both venous and arterial structures which is highly associated with increased mortality. The …
both venous and arterial structures which is highly associated with increased mortality. The …
[HTML][HTML] Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platform
Reliable, easy-to-handle phenotypic screening platforms are needed for the identification of
anti-SARS-CoV-2 compounds. Here, we present caspase 3/7 activity as a readout for …
anti-SARS-CoV-2 compounds. Here, we present caspase 3/7 activity as a readout for …
Intertwined pathways of complement activation command the pathogenesis of lupus nephritis
The complement system is involved in the origin of autoimmunity and systemic lupus
erythematosus. Both genetic deficiency of complement components and excessive …
erythematosus. Both genetic deficiency of complement components and excessive …
Autophagy-associated HMGB-1 as a novel potential circulating non-invasive diagnostic marker for detection of Urothelial Carcinoma of Bladder
Urothelial carcinoma of bladder (UBC), a highly prevalent urological malignancy associated
with high mortality and recurrence rate. Standard diagnostic method currently being used is …
with high mortality and recurrence rate. Standard diagnostic method currently being used is …
Non-invasive diagnostic potential of microRNA-203 in liquid biopsy of urothelial carcinoma of bladder
Increased CD44 antigen activity has been reported in recurrent cases of UBC. To date, no
reliable biomarker is available with high significance and specificity for non-invasive …
reliable biomarker is available with high significance and specificity for non-invasive …
RAGE pathway activation and function in chronic kidney disease and COVID-19
CS Curran, JB Kopp - Frontiers in Medicine, 2022 - frontiersin.org
The multi-ligand receptor for advanced glycation end-products (RAGE) and its ligands are
contributing factors in autoimmunity, cancers, and infectious disease. RAGE activation is …
contributing factors in autoimmunity, cancers, and infectious disease. RAGE activation is …
Diffuse proliferative glomerulonephritis in a patient with COVID-19 infection
VAG Flores, S Chicano, LP Resontoc… - BMJ Case Reports …, 2023 - casereports.bmj.com
COVID-19 primarily presents with respiratory involvement. Extrapulmonary manifestations
as the sole manifestation also occur although rare. The kidney, being one of the organs with …
as the sole manifestation also occur although rare. The kidney, being one of the organs with …
Targeting mucin hypersecretion in COVID-19 therapy
P Prasher, M Sharma - Future Medicinal Chemistry, 2022 - Taylor & Francis
Conclusion The emergence of successive waves of COVID-19 prompted the identification of
novel approaches for effectively managing the further spread of the pandemic. Mucus …
novel approaches for effectively managing the further spread of the pandemic. Mucus …
[HTML][HTML] COVID-19 相关性肾损伤研究进展
谢娜， 李悦， 刘晓， 陆蕾， 朱慧敏… - Advances in Clinical …, 2023 - hanspub.org
自2019 年12 月发现新型冠状病毒肺炎(Corona Virus Disease 2019, COVID-19) 以来,
该病以其高传染性, 高致病率, 成为威胁全球的突发公共卫生事件. COVID-19 …
该病以其高传染性, 高致病率, 成为威胁全球的突发公共卫生事件. COVID-19 …